Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2002
06/20/2002WO2001075076A3 33167, a novel human hydrolase and uses therefor
06/20/2002WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same
06/20/2002WO2001074897A3 Protein amf-1 to amf-10 and nucleic acids encoding the same
06/20/2002WO2001073059A3 38692 and 21117: dual specificity phosphatase molecules and uses therefor
06/20/2002WO2001072961A3 Novel compounds
06/20/2002WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
06/20/2002WO2001070231A3 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
06/20/2002WO2001068851A3 Polypeptides and nucleic acids encoding same
06/20/2002WO2001068068A3 Compounds capable of binding with the cytoskeleton
06/20/2002WO2001064755A3 Isoxazole gegen virale erkrankungen
06/20/2002WO2001060857A3 Compositions useful for regulating parkin gene activity
06/20/2002WO2001058948A3 USE OF NEUREGULIN-β AS AN INDICATOR AND/OR TARGET
06/20/2002WO2001056590A3 Utilization of protein kinase inhibitor alpha
06/20/2002WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
06/20/2002WO2001053487A3 Human sperm specific lysozyme-like proteins
06/20/2002WO2001053453A3 Novel bone marrow nucleic acids and polypeptides
06/20/2002WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer
06/20/2002WO2001048236A9 METHODS FOR IDENTIFYING AGENTS CAPABLE OF MODULATING PROTEIN KINASE C THETA (PKCυ) ACTIVITY
06/20/2002WO2001047528A3 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes
06/20/2002WO2001044445A8 Human lyases and associated proteins
06/20/2002WO2001036448A8 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
06/20/2002WO2001032693A3 Trp-protein-related mtr1 protein and dna sequence coding therefor
06/20/2002WO2001027154A3 Membrane translocating peptide drug delivery system
06/20/2002WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
06/20/2002WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof
06/20/2002WO2000065052A9 Bridge-1, a transcription factor
06/20/2002WO2000064935A9 A novel serotonin-gated anion channel
06/20/2002WO2000061752A9 Modified complement system regulators
06/20/2002WO2000061596A8 50 human secreted proteins
06/20/2002WO2000052159A9 Methods and reagents for inhibiting proliferation of smooth muscle cells
06/20/2002WO2000052158A9 Methods and reagents for inhibiting angiogenesis
06/20/2002WO2000049871A9 An anti-angiogenic kringle protein and its mutants
06/20/2002US20020077506 For therapy of inflammatory or painful disorder
06/20/2002US20020077468 Corticotropin-releasing factor2 receptors
06/20/2002US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis
06/20/2002US20020077463 16105, a novel protein human phosphatase and uses therefor
06/20/2002US20020077461 Pharmaceutical formulation
06/20/2002US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
06/20/2002US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects
06/20/2002US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering
06/20/2002US20020077454 Therapeutic pore-forming peptides
06/20/2002US20020077453 Novel staphylococcus peptides for bacterial interference
06/20/2002US20020077364 Thyroid hormone formulations
06/20/2002US20020077313 Methods and compositions for the diagnosis and treatment of cancer
06/20/2002US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders
06/20/2002US20020077308 Methods of treating colitis using STAT-4 anti-sense oligonucleotides
06/20/2002US20020077305 Genetic immunization with cationic lipids
06/20/2002US20020077298 Anti-fungal peptides
06/20/2002US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
06/20/2002US20020077294 Method of treating blood disorders
06/20/2002US20020077292 Targeting proteins to cells expressing mannose receptors via expression in insect cells
06/20/2002US20020077291 Method of treatment of tumors using transforming growth factor-alpha
06/20/2002US20020077289 Angiostatin and endostatin binding proteins and methods of use
06/20/2002US20020077287 28 human secreted proteins
06/20/2002US20020077286 Mechanically activated channel blocker
06/20/2002US20020077285 Identification and characterization of multiple splice variants of the mu-opioid receptor gene
06/20/2002US20020077284 Inhibitors of HIV membrane fusion
06/20/2002US20020077283 Blocking interaction of caveolin with a protein in vivo by administering peptide which comprises caveolin scaffolding domain
06/20/2002US20020077282 Method for treating cystic fibrosis
06/20/2002US20020077281 Fracture healing using pthrp analogs
06/20/2002US20020077280 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
06/20/2002US20020077278 Administering glatiramer acetate (Copolymer 1) to the subject for therapy of inflammatory, non-autoimmune central nervous system diseases
06/20/2002US20020077277 Method of treating chronic ulcers
06/20/2002US20020077276 Administering blood or soluble-receptor containing fraction to a mammal suffering from an acute inflammatory condition, wherein prior to administration blood has been contacted with tetracycline or a tetracycline-like compound
06/20/2002US20020077275 For therapy of central nervous system disorder including Alzheimer's disease, Parkinson's disease, stroke, post-polio syndrome and amyotrophic lateral sclerosis
06/20/2002US20020076834 Immunological detection of celiac disease; obtain body fluids, incubate with antibodies, monitor sample for immunological response to the presence of tissue transglutaminases
06/20/2002US20020076810 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders
06/20/2002US20020076804 Apparatus for detecting preferential cells and particles in a fluid
06/20/2002US20020076799 Compositions and methods for modulating TGF-beta signaling
06/20/2002US20020076798 Liver-specific gene expression cassettes, and methods of use
06/20/2002US20020076797 Purified and isolated piwi family genes and gene products and methods using same
06/20/2002US20020076796 2786, a novel human aminopeptidase
06/20/2002US20020076795 Novel TRF1 binding protein, methods of use thereof
06/20/2002US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
06/20/2002US20020076791 Cultured rodent cells; for use in generation of heterologous proteins
06/20/2002US20020076786 25869, a novel human carboxylesterase and uses thereof
06/20/2002US20020076785 Human polypeptide for use as an antitumor agent
06/20/2002US20020076784 Nucleotide sequences coding preferential polypeptide for use in the treatment of brain disorders, infections and viral diseases
06/20/2002US20020076782 Controlling nitric oxide generation in mammals; obtain mammal, administer modulator, monitor nitric oxide generation
06/20/2002US20020076776 Novel TCTS response regulator
06/20/2002US20020076774 Peptide for use in the detection of modulator of metabolic enzyme activity
06/20/2002US20020076766 Novel glucosaminidase
06/20/2002US20020076762 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, cell proliferative, and immunological disorder
06/20/2002US20020076760 G-protein coupled receptor HNFDS78 polypeptides
06/20/2002US20020076759 Cloning of vertebrate pheromone receptors and uses thereof
06/20/2002US20020076757 Nucleotide sequences for use in the treatment of tumors; antitumor agents; antiproliferative agents
06/20/2002US20020076756 Nucleotide sequences coding polypeptide for use in treatment of cancer and inflammation; for use as wound healing agent
06/20/2002US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
06/20/2002US20020076753 31939, a novel human leucine-rich repeat family member and uses thereof
06/20/2002US20020076752 33395, a novel human leucine-rich repeat family member and uses thereof
06/20/2002US20020076750 Peptide for use as tools in human therapeutics and diagnostics
06/20/2002US20020076749 Peptide; for use as tools in human diagnostics and therapeutics
06/20/2002US20020076748 Nucleotide sequences coding animal cell growth regulator; for us ein the prevent defective cell proliferation; for use as a wound healing agent
06/20/2002US20020076746 Macrophage inflammatory protein-4 (mip-4) polynucleotides
06/20/2002US20020076745 Human g-protein chemokine receptor hdgnr10 (ccr5 receptor)
06/20/2002US20020076737 Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use
06/20/2002US20020076736 Methods of affecting laminin 5 processing
06/20/2002US20020076721 Compositions and methods for the therapy and diagnosis of pancreatic cancer
06/20/2002US20020076719 Nucleotide sequences coding veterbrate telomere binding protein for use in the treatment of cancer and aging
06/20/2002US20020076712 Human RNase H and compositions and uses thereof
1 ... 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 ... 3163